462 related articles for article (PubMed ID: 27626445)
1. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
2. Design and construction of immune phage antibody library against Tetanus neurotoxin: Production of single chain antibody fragments.
Sadreddini S; Seifi-Najmi M; Ghasemi B; Kafil HS; Alinejad V; Sadreddini S; Younesi V; Jadidi-Niaragh F; Yousefi M
Hum Antibodies; 2015 Dec; 23(3-4):73-9. PubMed ID: 27472865
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
[TBL] [Abstract][Full Text] [Related]
6. Characterization of neutralizing monoclonal antibodies directed against tetanus toxin fragment C.
Yousefi M; Tahmasebi F; Younesi V; Razavi A; Khoshnoodi J; Bayat AA; Abbasi E; Rabbani H; Jeddi-Tehrani M; Shokri F
J Immunotoxicol; 2014; 11(1):28-34. PubMed ID: 23369087
[TBL] [Abstract][Full Text] [Related]
7. Novel neutralizing human monoclonal antibodies against tetanus neurotoxin.
Minamitani T; Kiyose K; Otsubo R; Ito T; Akiba H; Furuta RA; Inoue T; Tsumoto K; Satake M; Yasui T
Sci Rep; 2021 Jun; 11(1):12134. PubMed ID: 34108521
[TBL] [Abstract][Full Text] [Related]
8. Production of Recombinant Human scFv Against Tetanus Toxin Heavy Chain by Phage Display Technology.
Khalili E; Lakzaei M; Rasaee MJ; Aminian M
Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):303-9. PubMed ID: 26492617
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and immunoprotection of the functional TL-HN fragment derived from tetanus toxin.
Liu XY; Wei DK; Li ZY; Lu JS; Xie XM; Yu YZ; Pang XB
Vaccine; 2023 Nov; 41(46):6834-6841. PubMed ID: 37816654
[TBL] [Abstract][Full Text] [Related]
10. Comparative human and mouse antibody responses against tetanus toxin at clonal level.
Yousefi M; Younesi V; Bayat AA; Jadidi-Niaragh F; Abbasi E; Razavi A; Khosravi-Eghbal R; Asgarian-Omran H; Shokri F
J Immunotoxicol; 2016; 13(2):243-8. PubMed ID: 25990600
[TBL] [Abstract][Full Text] [Related]
11. Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice.
Zhang G; Yu R; Chi X; Chen Z; Hao M; Du P; Fan P; Liu Y; Dong Y; Fang T; Chen Y; Song X; Liu S; Li J; Yu C; Chen W
Int Immunopharmacol; 2021 Feb; 91():107297. PubMed ID: 33360088
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus vaccine candidate.
Yu R; Hou L; Yu C; Liu S; Ren J; Fang T; Zhang X; Chen W
Immunobiology; 2011 Apr; 216(4):485-90. PubMed ID: 20888666
[TBL] [Abstract][Full Text] [Related]
13. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing anti-diphtheria toxin scFv produced by phage display.
Khalili E; Lakzaei M; Aminian M
Biotechnol Lett; 2024 Jun; 46(3):385-398. PubMed ID: 38607601
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of tetanus toxin neutralization by native human monoclonal antibodies.
Wang Y; Wu C; Yu J; Lin S; Liu T; Zan L; Li N; Hong P; Wang X; Jia Z; Li J; Wang Y; Zhang M; Yuan X; Li C; Xu W; Zheng W; Wang X; Liao HX
Cell Rep; 2021 May; 35(5):109070. PubMed ID: 33951441
[TBL] [Abstract][Full Text] [Related]
16. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.
Yousefi M; Khosravi-Eghbal R; Reza Mahmoudi A; Jeddi-Tehrani M; Rabbani H; Shokri F
Hum Vaccin Immunother; 2014; 10(2):344-51. PubMed ID: 24126015
[TBL] [Abstract][Full Text] [Related]
18. Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction.
Lukić I; Marinković E; Filipović A; Krnjaja O; Kosanović D; Inić-Kanada A; Stojanović M
Toxicon; 2015 Sep; 103():135-44. PubMed ID: 26140841
[TBL] [Abstract][Full Text] [Related]
19. The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.
Yu R; Ji C; Xu J; Wang D; Fang T; Jing Y; Kwang-Fu Shen C; Chen W
Biomed Res Int; 2018; 2018():6057348. PubMed ID: 30687751
[TBL] [Abstract][Full Text] [Related]
20. [Construction and expression of recombinant prokaryotic expression vector for disulfide-stabilized anti-TeNT single-chain Fv antibody].
Wang H; Yu R; Zhang X; Ren J; Xie N; Fan H; Zhang J; Fang T; Yu C; Chen W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):60-4. PubMed ID: 23294719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]